Last week, around 42 companies announced a high dividend. I published all stocks with dividend growth from the recent week in the attached dividend list. In average, stocks from the list of the latest dividend growth stocks have increased their dividend payments by 15.51%.
It�� always good to see how the dividend growth strategy works. Some of the dividend growers have raised their payments forty times and more. The biggest names come from the oil and gas sector. Eni and Total are the two biggest stocks followed by the British spirit maker Diageo.
Five of the results have a double-digit dividend yield and seven yielding above five percent. Analysts and brokerage firms recommend more than half, 26 in total, of the dividend growth stocks.
Here are my favorite dividend growth stocks:
Teva Pharmaceuticals (TEVA) has a market capitalization of $34.16 billion. The company employs 45,948 people, generates revenue of $20.317 billion and has a net income of $1.956 billion. Teva Pharmaceuticals�� EBITDA amounts to $6.055 billion. The EBITDA margin is 29.80% (the operating margin is 10.85% and the net profit margin 9.63%).
5 Best High Dividend Stocks To Buy For 2014: Signet Jewelers Limited(SIG)
Signet Jewelers Limited operates as a specialty jewelry retailer in the United States, the United Kingdom, the Republic of Ireland, and the Channel Islands. The company retails jewelry, watches, and associated services. As of January 28, 2012, it operated a network of 1,318 stores in 50 states in the United States that trade nationally in malls and off-mall locations as ?Kay Jewelers?, and regionally under various mall-based brands, as well as operated as destination superstores under the ?Jared The Galleria Of Jewelry? trade name. The company also operated a network of 535 stores in the United Kingdom, including 14 stores in the Republic of Ireland and 3 in the Channel Islands under the ?H.Samuel?, ?Ernest Jones?, and ?Leslie Davis? trade names in high street locations and shopping malls. Signet Jewelers Limited was founded in 1950 and is based in Hamilton, Bermuda.
Advisors' Opinion:- [By Rich Duprey]
Specialty jeweler�Signet Jewelers� (NYSE: SIG ) announced today its third-quarter dividend of $0.15 per share, the same rate it paid last quarter after raising the payout 25% from $0.12 per share.
5 Best High Dividend Stocks To Buy For 2014: DaVita HealthCare Partners Inc (DVA)
DaVita HealthCare Partners Inc., formerly DaVita Inc., incorporated on April 4, 1994, is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In addition, as of December 31, 2011, it provided dialysis and administrative services to a total of 11 outpatient dialysis centers located in three countries outside of the United States. On September 2, 2011, the Company acquired CDSI I Holding Company, Inc., the parent company of dialysis provider DSI Renal Inc. In November 2011, the Company announced that its wholly owned European subsidiary, DV Care GmbH, acquired ExtraCorp AG. In January 2012, the Company acquired controlling interest in NephroLife. In September 2012, the Company announced that its new guest services contact center located in Centennial, Colorado was opened. On November 1, 2012, the Company announced the consummation of the merger of HealthCare Partners Holdings, LLC (HCP), with Seismic Acquisition LLC, a wholly owned subsidiary of the Company, with HCP as the surviving entity (the Merger). The Merger, HCP became a wholly owned subsidiary of the Company. In January 2013, the Company acquired nine dialysis centers from Fresenius Medical Care (FMC), provider of dialysis services and manufacturer of dialysis products.
During the year ended December 31, 2011, the Company acquired a total of 178 dialysis centers, eight of which were located outside of the United States, opened 65 new dialysis centers, sold two centers, merged seven centers, and divested a total of 30 dialysis cent! ers in connection with the acquisition of DSI. It also added three dialysis centers under management and administrative service agreements that are located outside of the United States and added one center in which the Company owns a minority equity interest. The Company�� United States dialysis and related laboratory services business accounts for approximately 93% of its consolidated net operating revenues. Its other ancillary services accounted for approximately 7% of its consolidated net operating revenues during the year ended December 31, 2011.
Dialysis and Related Lab Services
As of December 31, 2011, the Company operated or provided administrative services through a network of 1,809 outpatient dialysis centers located in the United States and 11 outpatient dialysis centers located outside the United States that are designed specifically for outpatient hemodialysis. Many of the Company�� outpatient dialysis centers offer certain support services for dialysis patients who prefer and are able to perform either home-based hemodialysis or peritoneal dialysis in their homes. Home-based hemodialysis support services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either home-based hemodialysis or peritoneal dialysis.
As of December 31, 2011, the Company provided hospital inpatient hemodialysis services, excluding physician services, to patients in approximately 900 hospitals throughout the United States. It renders these services for a contracted per-treatment fee that is individually negotiated with each hospital. When a hospital requests the Company�� services, the Company administers the dialysis treatment at the patient�� bedside or in a dedicated treatment room in the hospital, as needed. In 2011, hospital inpatient hemodialysis services accounted for approximately 4.5% of its total United S! tates dia! lysis treatments. The Company owns two licensed clinical laboratories, which specialize in ESRD patient testing. These laboratories provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients. Its laboratories provide these tests primarily for its network of ESRD patients throughout the United States. These tests are performed to monitor a patient�� ESRD condition, including the adequacy of dialysis, as well as other medical conditions. During 2011, it operated or provided management and administrative services to 33 outpatient dialysis centers located in the United States and three outpatient dialysis centers located outside of the United States, in which it either owns a minority equity investment or are wholly owned by third parties. These services are provided pursuant to management and administrative services agreements.
Ancillary services and strategic initiatives
DaVita Rx is a pharmacy that provides oral medications to DaVita�� patients with ESRD. HomeChoice Partners provides personalized infusion therapy services to patients typically in their own. Intravenous and nutritional support therapies are typically managed by registered and/or board-certified professionals, including pharmacists, nurses and dieticians in collaboration with the patient�� physician in support of the patient�� ongoing health care needs. VillageHealth provides advanced care management services to health plans and Government agencies for employees/members diagnosed with Chronic Kidney Disease (CKD) or ESRD. Lifeline provides management and administrative services to physician-owned vascular access clinics that provide surgical and interventional radiology services for dialysis patients. Lifeline also is the owner of one vascular access clinic. DaVita Clinical Research conducts research trials principally with dialysis patients and provides administrative support for research conducted by DaVita-affiliated nephrology practices. DaVita Neph! rology Pa! rtners offers practice management and administrative services to physicians who specialize in nephrology. Practice management and administrative services include operations management, information technology support, billing and collections, credentialing and coding, and other support functions.
The Company competes with Fresenius Medical Care.
Advisors' Opinion:- [By Monica Wolfe]
DaVita Health Care Partners (DVA)
Fournier�� second largest holding is in DaVita Health Care Partners. The guru holds on to 2,675,972 shares, representing 2.54% of the company�� shares outstanding and 6% of his total portfolio.
- [By Eric Volkman]
Shares of DaVita HealthCare Partners� (NYSE: DVA ) look like they might need a little care following the release of the company's Q3 results. For the quarter, revenues totaled $2.1 billion, an improvement over the $1.8 billion the company posted in the same period the previous year. Attributable net income went in the opposite direction, however, coming in at $136.6 million ($0.64 per diluted share) versus the Q3 2012 result of $144.7 million ($0.75).
- [By Keith Speights]
1. Keep it simple
Buffett likes to keep things simple and understand the business before he buys. DaVita Healthcare Partners (NYSE: DVA ) is a great example of this desired simplicity. The company provides dialysis services for patients with chronic kidney disease or end stage renal disease. Patients with these diseases can't survive without dialysis. DaVita provides the service. It doesn't get much more simple than that. - [By Holly LaFon]
Last quarter, there were four winners: Chihin, Errold, Luishernandez and Clemo69. They correctly guessed that Buffett bought DaVita (DVA), Wells Fargo (WFC) and IBM (IBM). Congratulations!
Top Oil Stocks To Buy For 2014: Alliance Fiber Optic Products Inc.(AFOP)
Alliance Fiber Optic Products, Inc. engages in the design, manufacture, and marketing of a range of fiber optic components and integrated modules incorporating these components to communications equipment manufacturers and service providers in North America, Europe, and Asia. The company offers interconnect devices that are used to connect optical fibers and components; couplers and splitters that are used to divide and combine optical power; and dense wavelength division multiplexing (DWDM) devices that separate and combine multiple specific wavelengths. Its connectivity products include connectivity modules; optical connectors, adapters, and cable assemblies; fused and planar fiber optical splitters and couplers; optical tap couplers and ultra low polarization dependent loss tap couplers; amplifier wave division multiplexing (WDM) couplers; optical fixed attenuators; and fused fiber WDM couplers. The company?s optical passive products comprise filter WDMs, amplifier fil ter WDMs, DWDMs, coarse WDMs, compact coarse WDMs, add/drop DWDM filters, optical isolators, optical bypass switches, and automatic variable optical attenuators. Its products are deployed in long-haul networks that connect cities; metropolitan networks that connect areas within cities; last mile access networks that connect to individual businesses and homes; and enterprise networks within businesses. The company sells its products to communications equipment manufacturers who incorporate its products into their systems and sell them to network service providers, as well as to other component manufacturers for resale or inclusion in their products. Alliance Fiber Optic Products, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Michael A. Robinson]
During the same five years, a small-cap play on high-speed digital networks did almost as well. Alliance Fiber Optic Products Inc. (Nasdaq: AFOP) has rallied nearly 785%, turning $25,000 into $221,250.
- [By Michael A. Robinson]
Enter Alliance Fiber Optic Products Inc. (Nasdaq: AFOP). Basically, Alliance helps make fiber-optic technology possible for homes and businesses.
- [By Monica Gerson]
Alliance Fiber Optic Products (NASDAQ: AFOP) shares rose 7.21% to $21.70. The volume of Alliance Fiber Optic Products shares traded was 397% higher than normal. Alliance Fiber Optic lifted its Q3 revenue outlook.
5 Best High Dividend Stocks To Buy For 2014: Occidental Petroleum Corporation(OXY)
Occidental Petroleum Corporation, together with its subsidiaries, operates as an oil and gas exploration and production company primarily in the United States. The company operates in three segments: Oil and Gas; Chemical; and Midstream, Marketing, and Other. The Oil and Gas segment explores for, develops, produces, and markets crude oil, natural gas liquids, and condensate and natural gas. Its domestic oil and gas operations are located in Texas, New Mexico, California, Kansas, Oklahoma, Utah, Colorado, North Dakota, and West Virginia; and international oil and gas operations are located in Bahrain, Bolivia, Colombia, Iraq, Libya, Oman, Qatar, the United Arab Emirates, and Yemen. As of December 31, 2010, this segment had proved reserves of approximately 3,363 million barrels of oil equivalent. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, and ethylene dichloride products; vinyls, such as vinyl chloride monomer and polyvinyl chloride; and other chemicals comprising chlorinated isocyanurates, resorcinol, sodium silicates, and calcium chloride products. The Midstream, Marketing, and Other segment gathers, treats, processes, transports, stores, purchases, and markets crude oil that includes natural gas liquids and condensate, as well as natural gas and carbon dioxide. This segment also involves in the power generation; and trades around its assets comprising pipelines and storage capacity, as well as oil and gas, other commodities, and commodity-related securities. Occidental Petroleum Corporation was founded in 1920 and is based in Los Angeles, California.
Advisors' Opinion:- [By Tyler Crowe and Aimee Duffy]
In the following video, Fool.com energy contributors Tyler Crowe and Aimee Duffy discuss a recent cease-fire within Occidental Petroleum (NYSE: OXY ) between the company's chairman of the board and former CEO Ray Irani, and the current CEO Steve Chazen. While Irani was rumored to have been looking to replace Chazen, support for Chazen from shareholders has resulted in the company announcing that he will remain CEO until at least the end of 2014. What could this mean for Occidental's share price, which has lagged the market for the past couple years? Tyler tells investors how this development will affect the company, and what to look for as Occidental moves into the future.
5 Best High Dividend Stocks To Buy For 2014: iShares MSCI Emerging Markets ETF (EEM)
iShares MSCI Emerging Markets Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of the MSCI Emerging Markets Index (the Index). The Index is designed to measure equity market performance in the global emerging markets. The Index was developed by Morgan Stanley Capital International Inc. as an equity benchmark for emerging market stock performance. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Benjamin Shepherd] The S&P 500 has gained 18.8 percent so far this year, but the emerging markets—using the iShares MSCI Emerging Markets Index (NYSE: EEM) as a proxy—have slid by nearly 6 percent. Investors are worried that China’s economy is slowing and the US Federal Reserve might end its quantitative easing program.
No comments:
Post a Comment